Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/13"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1823"
rdf:type	?:Evidence ?:Item
?:Evidence_assump_list_id	"4"
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:claim_assumed_valid_for_evidence_application_evidence_1823	?:theophylline_primary_total_clearance_enzyme_cyp1a2
?:content	"Theophylline When nefazodone (200 mg BID) was given to patients being treated with theophylline (600 to 1200 mg/day) for chronic obstructive pulmonary disease, there was no change in the steady-state pharmacokinetics of either nefazodone or theophylline. FEV1 measurements taken when theophylline and nefazodone were coadministered did not differ from baseline dosage (i.e., when theophylline was administered alone). Therefore, dosage adjustment is not necessary for either drug when coadministered."
dc:creator	"boycer"
dc:date	"01/11/2010 19:09:34"
rdfs:seeAlso	?:b1d149db-ad43-4f3f-aef1-fb0395ba4191

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ nefazodone_inhibits_cyp1a2, <http://purl.org/swan/1.2/swan-commons#citesAsRefutingEvidence>, evidence_1823 }

Context graph